Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, K. M.

Neurology, Vol 45, Issue 6 1211-1213, Copyright © 1995 by American Academy of Neurology

ARTICLES

Cardiac arrest following use of sumatriptan

KM Kelly
Department of Neurology, University of Michigan Medical Center, Ann Arbor, USA.

I report a 35-year-old woman with occult coronary artery disease who experienced cardiac arrest within minutes after receiving a first-time dose of subcutaneous sumatriptan for migraine. The patient was resuscitated, and subsequent serial cardiac enzymes indicated myocardial infarction. Because sumatriptan can cause coronary artery vasospasm, patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.


This article has been cited by other articles:


Home page
 NeurologyHome page
E. A. Wammes-van der Heijden, H. Rahimtoola, H.G.M. Leufkens, C. C. Tijssen, and A. C.G. Egberts
Risk of ischemic complications related to the intensity of triptan and ergotamine use.
Neurology, October 10, 2006; 67(7): 1128 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. M. Rose, A. P. Carson, C. P. Sanford, P. E. Stang, C. A. Brown, A. R. Folsom, and M. Szklo
Migraine and other headaches: Associations with Rose angina and coronary heart disease
Neurology, December 28, 2004; 63(12): 2233 - 2239.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
S. Bassi, R. Amersey, R. Henderson, and G K. Morris
Thyrotoxicosis, sumatriptan and coronary artery spasm
J R Soc Med, June 1, 2004; 97(6): 285 - 287.
[Full Text] [PDF]

Home page
 NeurologyHome page
A. M. VanDenBrink, R. W. M. van den Broek, R. de Vries, A. J. J. C. Bogers, C. J. J. Avezaat, and P. R. Saxena
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels
Neurology, November 28, 2000; 55(10): 1524 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. Liston, L. Bennett, B. Usher Jr, and J. Nappi
The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Intern Med, March 8, 1999; 159(5): 511 - 513.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. MaassenVanDenBrink, M. Reekers, W. A. Bax, M. D. Ferrari, and P. R. Saxena
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
Circulation, July 7, 1998; 98(1): 25 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. F. Meschia, M. D. Malkoff, and J. Biller
Reversible Segmental Cerebral Arterial Vasospasm and Cerebral Infarction: Possible Association With Excessive Use of Sumatriptan and Midrin
Arch Neurol, May 1, 1998; 55(5): 712 - 714.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.